Chen G H, Curtis J L, Mody C H, Christensen P J, Armstrong L R, Toews G B
Pulmonary Section, Department of Veterans Affairs Medical Center, Ann Arbor, MI.
J Immunol. 1994 Jan 15;152(2):724-34.
Cryptococcus neoformans, a pathogenic fungus usually acquired by inhalation, causes the most common lethal mycosis in AIDS. The resident lung phagocytes, alveolar macrophages (AM phi), inhibit growth of C. neoformans poorly unless activated by cytokines such as IFN-gamma. In this study, we examined the effect of rat AM phi of the potent hematopoietic and M phi-activating cytokine, granulocyte-macrophage CSF (GM-CSF), alone and in combination with other cytokines. Rat AM phi monolayers were preincubated with 0.1 to 1000 U/ml GM-CSF without or with other recombinant cytokines, and then were incubated with viable C. neoformans (strain H99/C3D). Growth inhibition was assessed by counting cryptococcal CFU at 24 and 48 h of coculture; AM phi proliferation was assessed by measuring both uptake of [3H]TdR and AM phi numbers. AM phi preincubated with GM-CSF for 5 days (but not for shorter periods) inhibited growth of C. neoformans. Anticryptococcal activity required direct contact of AM phi with C. neoformans, but once induced by preincubation, did not require continued exposure to GM-CSF. Induction of anticryptococcal activity by GM-CSF was dose dependent (maximal induction at 250 U/ml), and was due to both increased ingestion and killing. GM-CSF induced AM phi proliferation, but anticryptococcal activity was not due totally to increases in AM phi numbers, indicating AM phi activation by GM-CSF. GM-CSF-induced AM phi proliferation was increased by IL-6, unchanged by IL-8, and abolished by LPS or IFN-gamma. However, IL-6 did not increase GM-CSF-induced anticryptococal activity. The combination of GM-CSF and IFN-gamma showed rapid and sustained anticryptococcal activity, unlike either cytokine alone. Our in vitro data suggest that the combination of GM-CSF and IFN-gamma may have beneficial effects on host defense against C. neoformans in vivo.
新型隐球菌是一种通常通过吸入感染的致病真菌,可引发艾滋病患者中最常见的致命性真菌病。肺内常驻吞噬细胞,即肺泡巨噬细胞(AM phi),除非被诸如γ干扰素等细胞因子激活,否则对新型隐球菌生长的抑制作用很差。在本研究中,我们单独以及联合其他细胞因子检测了强效造血和巨噬细胞激活细胞因子粒细胞-巨噬细胞集落刺激因子(GM-CSF)对大鼠AM phi的影响。大鼠AM phi单层细胞在无或有其他重组细胞因子的情况下,用0.1至1000 U/ml的GM-CSF预孵育,然后与活的新型隐球菌(菌株H99/C3D)共同孵育。通过在共培养24小时和48小时时计数隐球菌集落形成单位(CFU)来评估生长抑制情况;通过测量[3H]胸腺嘧啶核苷(TdR)摄取量和AM phi数量来评估AM phi增殖情况。用GM-CSF预孵育5天(而非较短时间)的AM phi可抑制新型隐球菌的生长。抗隐球菌活性需要AM phi与新型隐球菌直接接触,但一旦通过预孵育诱导产生,就不需要持续暴露于GM-CSF。GM-CSF诱导的抗隐球菌活性呈剂量依赖性(在250 U/ml时诱导作用最强),且是由于吞噬和杀伤作用增强。GM-CSF诱导AM phi增殖,但抗隐球菌活性并非完全归因于AM phi数量的增加,这表明GM-CSF激活了AM phi。GM-CSF诱导的AM phi增殖可被白细胞介素-6(IL-6)增强,不受白细胞介素-8(IL-8)影响,而被脂多糖(LPS)或γ干扰素消除。然而,IL-6并未增强GM-CSF诱导的抗隐球菌活性。与单独使用任何一种细胞因子不同,GM-CSF和γ干扰素的联合使用显示出快速且持续的抗隐球菌活性。我们的体外数据表明,GM-CSF和γ干扰素的联合使用可能对体内宿主抵御新型隐球菌具有有益作用。